Discover your next big idea for life sciences at PACK EXPO Las Vegas
Experience a breakthrough in life sciences packaging—explore solutions from 2,300 suppliers spanning all industries, all in one place this September

Aviragen and Vaxart Merge for 3 Oral Vaccines

Aviragen Therapeutics and Vaxart are merging and plan to develop oral vaccines for influenza, norovirus and RSV.

Vaxart logo / Image: Vaxart
Vaxart logo / Image: Vaxart

A recent FiercePharma article discussed a new merger that aims to create the first approved vaccines for norovirus and RSV, as well as a new influenza vaccine. The merger between Aviragen Therapeutic and Vaxart will likely close in early 2018, and keep Vaxart’s name and possibly the proposed ticker symbol “VXRT.”

The product furthest along in development is a promising H1N1 influenza tablet vaccine that is taken orally. In a head-to-head phase 2 challenge study, the tablet reduced the disease by 39%, compared to 27% by market leader Fluzone quadrivalent. The CDC estimates that only 59% of adults and 43.3% of children got flu shots last year; perhaps an oral alternative will perform better.

FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
FDA warning letters surge - is your team prepared?
List: Digitalization Companies From PACK EXPO
Looking for CPG-focused digital transformation solutions? Download our editor-curated list from PACK EXPO featuring top companies offering warehouse management, ERP, digital twin, and MES software with supply chain visibility and analytics capabilities—all tailored specifically for CPG operations.
Download Now
List: Digitalization Companies From PACK EXPO